Header cover image

Chinese (SSE) Healthcare Distributors Industry Analysis

UpdatedMay 28, 2024
DataAggregated Company Financials
Companies23
  • 7D-2.1%
  • 3M0.9%
  • 1Y-17.2%
  • YTDn/a

Over the last 7 days, the Healthcare Distributors industry has dropped 3.3%, driven by Huadong Medicine declining 5.9%. On the other hand China Reform Health Management and Services Group is actually up 6.7%. Overall the industry is down 17% in 12 months. Earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the Chinese Healthcare Distributors Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 28 May 2024CN¥313.4bCN¥904.3bCN¥16.5b17.4x19x0.3x
Thu, 25 Apr 2024CN¥305.8bCN¥904.4bCN¥14.9b16.1x20.5x0.3x
Sat, 23 Mar 2024CN¥304.8bCN¥897.3bCN¥15.7b13.9x19.4x0.3x
Mon, 19 Feb 2024CN¥297.1bCN¥894.8bCN¥15.5b14.2x19.2x0.3x
Wed, 17 Jan 2024CN¥309.3bCN¥893.5bCN¥15.5b14.5x20x0.3x
Fri, 15 Dec 2023CN¥333.8bCN¥893.5bCN¥15.5b15.7x21.6x0.4x
Sun, 12 Nov 2023CN¥338.5bCN¥893.5bCN¥15.5b15.9x21.9x0.4x
Tue, 10 Oct 2023CN¥335.2bCN¥897.9bCN¥15.9b16.2x21x0.4x
Thu, 07 Sep 2023CN¥322.8bCN¥897.9bCN¥15.9b15.9x20.2x0.4x
Sat, 05 Aug 2023CN¥342.8bCN¥869.7bCN¥17.2b14.4x19.9x0.4x
Mon, 03 Jul 2023CN¥363.3bCN¥863.1bCN¥17.1b15x21.2x0.4x
Wed, 31 May 2023CN¥366.1bCN¥863.1bCN¥17.1b15.2x21.4x0.4x
Fri, 28 Apr 2023CN¥377.8bCN¥845.9bCN¥19.7b17.4x19.2x0.4x
Sun, 26 Mar 2023CN¥347.3bCN¥821.5bCN¥18.7b15.5x18.6x0.4x
Tue, 21 Feb 2023CN¥351.0bCN¥821.4bCN¥18.2b15.4x19.3x0.4x
Thu, 19 Jan 2023CN¥337.0bCN¥821.4bCN¥18.2b14.4x18.5x0.4x
Sat, 17 Dec 2022CN¥353.7bCN¥821.1bCN¥18.2b18.4x19.4x0.4x
Mon, 14 Nov 2022CN¥325.5bCN¥821.1bCN¥18.2b18.2x17.9x0.4x
Wed, 12 Oct 2022CN¥267.8bCN¥764.7bCN¥16.8b14.6x15.9x0.4x
Fri, 09 Sep 2022CN¥287.1bCN¥764.7bCN¥16.8b17.8x17.1x0.4x
Sun, 07 Aug 2022CN¥293.4bCN¥759.0bCN¥16.1b21.6x18.2x0.4x
Tue, 05 Jul 2022CN¥329.5bCN¥766.9bCN¥17.6b16x18.7x0.4x
Thu, 02 Jun 2022CN¥301.7bCN¥766.9bCN¥17.6b15.5x17.2x0.4x
Sat, 30 Apr 2022CN¥292.3bCN¥764.6bCN¥18.0b12.5x16.2x0.4x
Mon, 28 Mar 2022CN¥331.4bCN¥753.3bCN¥19.3b16.5x17.2x0.4x
Wed, 23 Feb 2022CN¥297.7bCN¥750.9bCN¥19.7b14.8x15.1x0.4x
Fri, 21 Jan 2022CN¥316.8bCN¥749.6bCN¥19.6b14.7x16.2x0.4x
Sun, 19 Dec 2021CN¥293.8bCN¥748.6bCN¥19.5b13.6x15.1x0.4x
Tue, 16 Nov 2021CN¥279.7bCN¥746.1bCN¥19.4b13.1x14.4x0.4x
Thu, 14 Oct 2021CN¥287.2bCN¥738.6bCN¥20.2b14.4x14.2x0.4x
Sat, 11 Sep 2021CN¥272.7bCN¥737.2bCN¥20.1b13x13.6x0.4x
Mon, 09 Aug 2021CN¥279.8bCN¥737.0bCN¥20.0b12.2x14x0.4x
Price to Earnings Ratio

17.7x


Total Market Cap: CN¥325.3bTotal Earnings: CN¥18.4bTotal Revenue: CN¥705.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Healthcare Distributors Industry Price to Earnings3Y Average 18x202220232024
Current Industry PE
  • Investors are relatively neutral on the Chinese Healthcare Distributors industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 18.0x.
  • The industry is trading close to its 3-year average PS ratio of 0.39x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Distributors industry have declined 3.6% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.6% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Chinese Healthcare Distributors compare with similar industries?

CN Market-2.34%
Healthcare-3.26%
Healthcare Services-3.90%
Healthcare Distributors-2.12%
Managed Healthcare0%
Healthcare Facilities-5.43%
Healthcare Services-7.14%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
503 China Reform Health Management and Services GroupCN¥8.462.7%
+CN¥216.5m
-33.9%PS25.8x
601607 Shanghai Pharmaceuticals HoldingCN¥18.290.1%
+CN¥74.1m
-20.3%PE17.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

963

CN¥30.90

Huadong Medicine

7D

-5.9%

1Y

-24.1%

950

CN¥5.78

C.Q. Pharmaceutical Holding

7D

-3.8%

1Y

-18.0%

503

CN¥8.46

China Reform Health Management and Services Group

7D

2.7%

1Y

-33.9%